Susquehanna International Group, LLP Repare Therapeutics Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$4.53 - $8.41 $67,044 - $124,468	-14,800 Reduced 54.21%	12,500 $58,000
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $661,066 - $2.42 Million	-205,300 Reduced 88.26%	27,300 $199,000
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $1.9 Million - $3.03 Million	232,600 New	232,600 $2.81 Million
Q1 2023 May 16, 2023	BUY	$9.32 - $15.06 $93,200 - $150,600	10,000 New	10,000 $98,000
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $33,553 - $45,211	2,900 Added 6.04%	50,900 $617,000
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $312,650 - $549,080	37,000 Added 336.36%	48,000 $672,000
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $3,414 - $6,564	-300 Reduced 2.65%	11,000 $157,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $51,420 - $70,480	2,000 Added 21.51%	11,300 $297,000
Q2 2021 Aug 11, 2021	BUY	$30.1 - $34.85 $279,930 - $324,105	9,300 New	9,300 $290,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $139M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.